Searchable abstracts of presentations at key conferences in endocrinology

ea0041s11.2 | New Developments in subclinical thyroid disease | ECE2016

Subclinical thyroid disease and clinical outcomes: lessons from large individual participant-based analyses from the Thyroid Studies Collaboration

Rodondi Nicolas

To clarify the risks associated with subclinical thyroid dysfunction, we built in 2008 the Thyroid Studies Collaboration and collected into individual participant data from 70 000 participants from 17 prospective cohorts. We first clarified the risks of coronary heart disease, heart failure and mortality and assessed the contribution of autoimmunity on the risks of cardiovascular diseases. We also assessed the risk of stroke associated with subclinical thyroid dysfunction. The...

ea0056oc1.3 | Benign thyroid diseases | ECE2018

Thyroid hormone replacement therapy for subclinical hypothyroidism in adults: systematic review and meta-analysis of randomized-controlled trials

Snel Marieke , Feller Martin , Moutzouri Elisavet , Ford Ian , Gussekloo Jacobijn , Kearney Patricia , Mooijaart Simon , Quinn Terry , Aujesky Drahomir , Stott David , Westendorp Rudi , Rodondi Nicolas , Dekkers Olaf

Introduction: Although widely prescribed, the benefit of thyroid hormone replacement in subclinical hypothyroidism (SHypo) is unclear. We performed a systematic review and meta-analysis of randomized controlled trails (RCTs) to assess the impact of thyroid hormone therapy on clinical outcomes.Methods: We followed the PRISMA guidelines and registered the study protocol on PROSPERO (CRD42017055536). We searched PubMed, Embase, Web of Science, COCHRANE Libr...

ea0084op-06-28 | Oral Session 6: Hypothyroidism | ETA2022

The optimal ranges of thyroid function based on the risk of cardiovascular disease and mortality: an individual participant data meta-analysis

Xu Yanning , Derakhshan Arash , Wildisen Lea , Hysaj Ola , Iacoviello Massimo , Ceresini Graziano , Ferrucci Luigi , Iervasi Giorgio , Pingitore Alessandro , Vaes Bert , Gussekloo Jacobijn , Medici Marco , Galesloot Tessel , P. F. Dullaart Robin , J.L. Bakker Stephan , Wouter Jukema J. , Trompet Stella , Westendorp Rudi , Ittermann Till , Volzke Henry , Dorr Marcus , Schmidt Borge , Fuhrer Dagmar , J. Wareham Nicholas , Boelaert Kristien , Razvi Salman , P. J. Vanderpump Mark , Muendlein Axel , Drexel Heinz , Bensenor Isabela , Sgarbi Jose , C. Bauer Douglas , A. Fink Howard , M. Rhee Connie , Azizi Fereidoun , Imaizumi Misa , B. Yeap Bu , Hankey Graeme , J. Brown Suzanne , P. Walsh John , Korevaar Tim , Rodondi Nicolas , R. Cappola Anne , Peeters Robin , Chaker Layal , the Thyroid Studies Collaboration for

Background and Objective: Thyroid function reference ranges are statistically defined by the 2.5th and 97.5th percentiles, which do not account for potential risk of clinical outcomes. We aimed to define the optimal ranges of thyroid-stimulating hormone (TSH) and free thyroxine (FT4), based on the risk of cardiovascular disease (CVD) and mortality.Methods: We performed an individual-participant data analysis and identified prospecti...